经蝶窦入路垂体腺瘤手术中术中超声的应用:系统综述
该系统综述检索了PubMed 1996年1月至2016年1月的文献,最终纳入10项研究(1项队列研究、7项病例系列和2项病例报告),评估经蝶窦垂体腺瘤手术中术中超声的安全性和有效性。仅有的对照研究显示,库欣病患者术中使用超声的缓解率为89.7%(61/68),未使用者为83.8%(57/68);所有研究均报告外科医生经验性认为术中超声有帮助。结论认为证据有限且质量低,术中超声似乎是安全有效的技术辅助手段。
要点
- 纳入10项研究,仅1项为对照研究,其余为病例系列或病例报告。
- 对照研究中库欣病缓解率:术中使用超声89.7%(61/68) vs 未使用83.8%(57/68)。
- 两项研究报告原型探头故障或尺寸过大导致假阳性或无法安全进入蝶窦。
核心结论
- 尽管证据有限且质量低,术中超声似乎是经蝶窦垂体腺瘤手术安全有效的技术辅助手段。
- 超声技术的进步可能使此类设备得到更广泛的应用。
研究设计与样本
- 系统综述,检索PubMed数据库1996年1月至2016年1月的相关文献,并核查参考文献列表和征求专家意见以补充文献。
- 最终纳入10项研究,包括1项队列研究、7项病例系列和2项病例报告。
主要发现
- 一项研究报道其原型探头发生故障,导致2例出现假阳性结果。
- 另一项研究的原型探头尺寸过大,无法安全进入蝶窦,涉及2例。
- 除此之外,未报告与术中超声使用直接相关的安全性问题。
- 在唯一的对照研究中,库欣病患者术中使用超声的缓解率为89.7%(61/68),未使用者为83.8%(57/68)。
- 所有研究均报告外科医生经验性认为术中超声有帮助。
关键数值与推荐
- 库欣病患者接受经蝶窦手术,术中使用术中超声者缓解率为89.7%(61/68)。
- 库欣病患者接受经蝶窦手术,术中未使用术中超声者缓解率为83.8%(57/68)。
局限性
- 可获得的证据有限且质量低(原文述limited and low-quality evidence)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transsphenoidal surgery is the gold standard for pituitary adenoma resection. However, despite advances in microsurgical and endoscopic techniques, some pituitary adenomas can be challenging to cure. OBJECTIVE: We sought to determine whether, in patients undergoing transsphenoidal surgery for pituitary adenoma, intraoperative ultrasound is a safe and effective technologic adjunct. METHODS: The PubMed database was searched between January 1996 and January 2016 to identify relevant publications that 1) featured patients undergoing transsphenoidal surgery for pituitary adenoma, 2) used intraoperative ultrasound, and 3) reported on safety or effectiveness. Reference lists were also checked, and expert opinions were sought to identify further publications. RESULTS: Ultimately, 10 studies were included, comprising 1 cohort study, 7 case series, and 2 case reports. One study reported their prototype probe malfunctioned, leading to false-positive results in 2 cases, and another study' prototype probe was too large to safely enter the sphenoid sinus in 2 cases. Otherwise, no safety issues directly related to use of intraoperative ultrasound were reported. In the only comparative study, remission occurred in 89.7% (61/68) of patients with Cushing disease in whom intraoperative ultrasound was used, compared with 83.8% (57/68) in whom it was not. All studies reported that surgeons anecdotally found intraoperative ultrasound helpful. CONCLUSIONS: Although there is limited and low-quality evidence available, the use of intraoperative ultrasound appears to be a safe and effective technologic adjunct to transsphenoidal surgery for pituitary adenoma. Advances in ultrasound technology may allow for more widespread use of such devices.
引用
- Marcus HJ, Vercauteren T, Ourselin S, et al. Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma: Systematic Review [corrected]. World Neurosurg. 2017. PMID: 28736351. doi:10.1016/j.wneu.2017.07.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。